Condition: Bladder Cancer · Muscle-Invasive Bladder Carcinoma · Urothelial Carcinoma · Sponsor: Thomas Jefferson University
Subjects will be randomized into 2 groups (stent or no stent) prior to radical cystectomy with ileal conduit urinary diversion (RCIC). They will follow the standard of care and be enrolled in the study for 12 months post-op. Risk of post-op complications will be analyzed.
This description comes directly from the study's public registry record.
Mihir S Shah, MD · 215-955-6961 · Mihir.Shah@jefferson.edu
Always discuss trial participation with your own doctor first.
| Thomas Jefferson University Hospital | Philadelphia, Pennsylvania, United States | Recruiting |
| Jefferson Einstein Philadelphia Hospital | Philadelphia, Pennsylvania, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07234968